1 / 30

Molecular Biological and Genetic Techniques for Studying Learning and Memory Thomas Gould, Ph.D.

Molecular Biological and Genetic Techniques for Studying Learning and Memory Thomas Gould, Ph.D. Department of Psychology Temple University. Transgenic Techniques. Inserts a novel gene into genome

swarthout
Download Presentation

Molecular Biological and Genetic Techniques for Studying Learning and Memory Thomas Gould, Ph.D.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Molecular Biological and Genetic Techniques for Studying Learning and Memory Thomas Gould, Ph.D. Department of Psychology Temple University

  2. Transgenic Techniques • Inserts a novel gene into genome • Developed in the early 1980s by John Gordon and by Ralph Brinster and Richard Palmiter and their co-workers. • Although all of the cells in the body contain an identical set of genes, some genes are active in only one or a few tissues. • The two main parts of a gene are the regulatory region and the protein-coding region. • When the right combination of proteins binds to specific sites along the DNA in the regulatory region, the gene is switched on, and the protein-coding region becomes active.

  3. Transgenic Techniques • Make your DNA • Using recombinant DNA methods, build molecules of DNA containing the promoter and structural gene you desire • Insert into plasmid DNA to copy • Cloning • Transform ES cells in culture • Expose the cultured cells to the DNA to allow incorporation • Select for successfully transformed cells • neor (a gene that encodes an enzyme that inactivates the antibiotic neomycin and its relatives, like the drug G418, which is lethal to mammalian cells) is part of the vector • Expose embyronic stem cells to G418 • Inject surviving cells into the inner cell mass (ICM) of mouse blastocysts.

  4. Transgenic Techniques • Embryo transfer • Prepare a pseudopregnant mouse (by mating a female mouse with a vasectomized male - stimulus of mating elicits the hormonal changes needed to make her uterus receptive) • Transfer the embryos into her uterus. • No more than one-third will implant successfully • Test offspring • Remove a small piece of tissue from the tail and examine its DNA for the desired gene • No more than 10-20% will have it, and they will be heterozygous for the gene • Establish a transgenic strain • Mate two heterozygous mice and screen their offspring for the 1:4 that will be homozygous for the transgene • Or create dominant transgene • Mating these will found the transgenic strain.

  5. Knockout Mice • DNA that has been mutated is injected into embryonic stem cells in cell culture • Stem cells are injected into blastocysts that will incorporate the cells • Cells need to be incorporated into the gametes to be useful (low probability) • Mice born with this mutation are called chimeras and have one copy of the mutated DNA • Chimeras are crossbred producing ¼ offspring with two copies of mutated gene

  6. Cerebellar Circuit

  7. Eye-Blink Circuit Parallel Fibers Climbing Fibers Cerebellar Cortex GranuleCells Inferior Olive Cerebellar Interpositus Nucleus Mossy Fibers Red Nucleus Trigeminal Nucleus (US) Lateral Pontine Nucleus(CS) Abducens Nucleus Reticular Formation Eye-Blink

  8. Genetic Analysis of Cerebellar Plasticity • Current goals • Use genetic manipulation to examine effects of pre- and postsynaptic up and down regulation of PKA and CREB at the granule cell Purkinje cell synapse on classical conditioning of the eye-blink reflex and on cerebellar LTP and LTD • Use the tetracycline system to temporally control gene expression • Examine Developmental issues • Study acquisition vs extinction • Use Genetic Manipulation to examine age-related changes in learning and memory

  9. Temporal Control of Transgene Expression • Tetracycline Responsive Transciptional Activator (tTA) is used to temporally control transgene expression • tTA stimulates gene expression from its cognate promoter • Doxycycline inhibits promoter activity

  10. Spatial and Temporal Control of Transgene Expression Double Transgenic Mice tTA-Gene Region Specific Promoter tTA _ Doxycycline + Effector Gene tTA responsive Promoter

  11. Effector Genes • R(AB) transgene is the dominant negative form of the regulatory subunit of PKA • C(QR) transgene has a mutation in the catalytic subunit which up regulates PKA • ICER (inducible cAMP early repressor) transgene down regulates CREB via transcription factor repression • CREBY/F transgene promotes CREB gene expression via constitutive phosphorylation of a mutant polypeptide at Ser 133.

  12. Region Specificity • 6 promoter from the type A gamma-aminobutyric acid receptor alpha6-subunit gene is only expressed in cerebellar granule cells • L7 promoter is from a Purkinje cell-specific gene.

  13. Spatial and Temporal Control of PKA Expression in Cerebellar Granule Cells Double Transgenic Mice tTA-Gene 6 Promoter tTA + _ Doxycycline R(AB) Transgene tTA responsive Promoter

  14. Spatial and Temporal Control of PKA Expression in Cerebellar Purkinje Cells Double Transgenic Mice tTA-Gene L7 Promoter tTA + _ Doxycycline R(AB)Transgene tTA responsive Promoter

  15. Microarrays • Method of examining changes in gene expression associated with event, drug, or disease

  16. Probing Microarrays

  17. Delay Contextual Fear Conditioning Training Day Testing Day Context - Shock US Association Hippocampal Dependent Test Freezing to Context Clicker CS - Shock US Association Hippocampal Independent Test Freezing to CS in Altered Context CS = 30 sec white noise, US = 0.5 mA 2 sec shock, ITI 2 minutes, 2 trials

  18. Duration of Enhancement • Nicotine must be administered on training and testing days for enhancement. Will enhancement be seen in the absence of nicotine at a second test? • Groups • Nicotine pre-training and prior to testing at 24 hours; retest one week later with no nicotine • Saline pre-training and prior to testing at 24 hours; retest one week later with no nicotine

  19. Nicotine Alters Gene Expression • Long-term memory for contextual fear conditioning remained enhanced at later retests in the absence of nicotine (Gould and Higgins, 2003) • Long-term memory is thought to be stored in neurons as a result of changes in gene expression induced by the activation of intracellular signaling pathways (reviewed in Abel and Lattal, 2001) • Nicotine can activate cellular and molecular processes involved in the chain of events linking synaptic activity to gene expression (Berg and Conroy, 2002; Dajas-Bailador et al., 2002) • Use microarray analysis to determine if hippocampus-dependent learning in the presence of nicotine results in a different pattern of gene expression than learning in the absence of nicotine

  20. Affymetrix Microarrays 6000 mouse genes per chip Arrayed as oligonucleotides; 20 per gene Mismatch oligonucleotides used as controls Does nicotine alter gene expression in the hippocampus during fear conditioning?

  21. Microarray Experimental Design Train and test mice: nic/nic; sal/sal Prepare mRNA from hippocampus, amygdala, prefrontal; label cRNA prepared from mRNA; hybridize to mouse Affymetrix microarray MGU74Av2 Compare gene expression levels; compare to “normal” variance in these brain regions; compare to mice treated with nicotine or saline and not conditioned Confirm using real-time PCR

  22. Nicotine and Saline Mean Hippocampi Log Base 2 Expression Values • Each dot represents the expression level of a single probe set (Gene) on both chips. • Dots outside the line of (y=x) are outliers potentially represent genes that affected by the nicotine manipulation. • Manipulation does not affect most of the genome. The are about 20 genes that appear affected between the expression levels of 5-11--representing about 1.5 fold changes.

  23. Differences between nicotine and saline arrays were specific because there were no global changes in average expression between the groups 20 Genes with Significantly Higher Expression in Nicotine Group 3 Genes with Significantly Higher Expression in Saline Group Changes In Gene Expression

  24. Potential Genes of Interest • Potassium voltage-gated channel, shaker-related subfamily, beta member 1 • Accessory potassium channel protein which modulates the activity of the pore-forming alpha subunit & alters the functional properties of kv1.1 and kv1.4 • Centrin 2 • Coding for calmodulin • Annexin A3 • Inhibitor of phospholipase a2 • Nucleosome assembly protein 1-like 1 • May be involved in modulating chromatin formation and contribute to regulation of cell proliferation • Mitogen activated protein kinase 8 • phosphorylating a number of transcription factors • Mitogen activated protein kinase 10 • phosphorylating a number of transcription factors

  25. Conclusions • Nicotine enhances hippocampus-dependent versions of fear conditioning • Nicotine enhancement of fear conditioning is long-lasting and this long-lasting memory is expressed in the absence of nicotine • Nicotine administration during training and initial testing is associated with an up-regulation of genes that may have a role in synaptic plasticity

  26. Acknowledgements • Transdisciplinary Tobacco Use Research Center UPENN • American Federation of Aging Research • The PA Department of Health (TG)

  27. Thanks Gould Lab Jennifer Davis Mike Lewis Olivia Rossebo Dan Moore Steve Higgins Joel Lommock Alla Kryss Collaborators and Colleagues Ted Abel, Ph.D. UPENN Sheree Logue, Ph.D. Aventis Pharmaceutical Jeanne Wehner, Ph.D. Univ Colorado Diana Woodruff-Pak, Ph.D. Temple Univ

More Related